Twelve Bio

📍 Copenhagen, Denmark👥 1 employees💰 Last funded Sep 2020
Biotechnology Research🌐 ensoma.com
Website LinkedIn
Twelve Bio was acquired by Ensoma in February 2023. Ensoma is based out of Boston, MA, with a research facility and office in Copenhagen, Denmark. We are integrating Twelve Bio’s proprietary gene editing technology into Ensoma’s Engenious™ platform to move closer to our goal of developing one-time in vivo treatments that can precisely engineer specific cells to cure diseases from within. Learn more at www.ensoma.com.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Twelve Bio?
Twelve Bio has 1 investors on record on gritt.io.
When did Twelve Bio last raise funding?
The most recent investment in Twelve Bio recorded on gritt.io was in September 2020.
What industry is Twelve Bio in?
Twelve Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Twelve Bio based?
Twelve Bio is headquartered in Copenhagen, Denmark.